Cargando…
PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses In Silico and In Vitro Assays
Background: Latent tuberculosis infection (LTBI) is the primary source of active tuberculosis (ATB), but a preventive vaccine against LTBI is lacking. Methods: In this study, dominant helper T lymphocyte (HTL), cytotoxic T lymphocyte (CTL), and B-cell epitopes were identified from nine antigens rela...
Autores principales: | Jiang, Fan, Peng, Cong, Cheng, Peng, Wang, Jie, Lian, Jianqi, Gong, Wenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145841/ https://www.ncbi.nlm.nih.gov/pubmed/37112768 http://dx.doi.org/10.3390/vaccines11040856 |
Ejemplares similares
-
Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis
por: Jiang, Fan, et al.
Publicado: (2023) -
In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection
por: Cheng, Peng, et al.
Publicado: (2022) -
Current Update
on Rotavirus in-Silico Multiepitope
Vaccine Design
por: Kuri, Pooja R., et al.
Publicado: (2022) -
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation
por: Srivastava, Sukrit, et al.
Publicado: (2020) -
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes
por: Akbari, Elahe, et al.
Publicado: (2021)